J9047 Injection, carfilzomib, 1 milligrams
Also known as: carfilzomib, Kyprolis
Intravenous injection of carfilzomib, an epoxyketone proteasome inhibitor, dosed per 1 milligram.
In Plain Language
protein-blocking cancer drug; irreversible proteasome inhibitor
Clinical Context
Used to treat relapsed or refractory multiple myeloma. Irreversible proteasome inhibitor with enhanced selectivity.
RVU Information
CPT J9047 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9047?
CPT J9047 (Injection, carfilzomib, 1 milligrams) is a J Codes (Drugs) code. Intravenous injection of carfilzomib, an epoxyketone proteasome inhibitor, dosed per 1 milligram.
How is J9047 administered?
CPT J9047 is administered by a healthcare provider, typically via injection or infusion. Used to treat relapsed or refractory multiple myeloma. Irreversible proteasome inhibitor with enhanced selectivity. It is used by Hematology/Oncology, Medical Oncology.
When is CPT J9047 used?
Used to treat relapsed or refractory multiple myeloma. Irreversible proteasome inhibitor with enhanced selectivity.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.